The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global neurosurgery devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson’s, Alzheimer’s, depression, epilepsy and traumatic brain and spinal cord injury. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators and rongeurs. These tools aid in conducting microsurgeries, discectomies, elevating the periosteum below temporalis muscle and adjusting the skull bone during surgeries.
The increasing prevalence of various neurological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to neurological and other medical ailments, is also providing a boost to the market growth. There is also an increasing health consciousness and awareness among the masses regarding the availability of effective treatment alternatives for neurological disorders, which is contributing to the market growth. Consequently, there is a growing preference for neuroendoscopy surgeries over traditional brain surgeries. For instance, various neurostimulation devices are used to send electrical impulses to the targeted sacral nerves and perform deep brain stimulation. Additionally, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents and balloon catheters, are acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurosurgery devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, application and end-user.
Breakup by Product Type:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra Lifesciences, Johnson & Johnson Services Inc., Medtronic Inc., Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc., Stryker Corporation, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra Lifesciences, Johnson & Johnson Services Inc., Medtronic Inc., Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at